Russell Frank Company’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Russell Frank Company’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-200,000	Closed	-$94K	–	2994
2014 Q2	$94K	Hold	200,000	–	–	﹤0.01%	2651
2014 Q1	$71K	Sell	200,000 -200,000	-50%	-$74.3K	﹤0.01%	2706
2013 Q4	$168K	Sell	400,000 -500,000	-56%	-$604K	﹤0.01%	2594
2013 Q3	$1.77M	Hold	900,000	–	–	﹤0.01%	1927
2013 Q2	$1.63M	Buy	+900,000	New	+$1.58M	﹤0.01%	1868

Other funds holding GCVRZ

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

CPM

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Russell Frank Company's GCVRZ Position: Q3 2014 in Review

Russell Frank Company sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2014, closing a stake of 200,000 shares — an estimated $94K sold.

Russell Frank Company first reported a position in GCVRZ in Q2 2013 and held it in 5 quarters. The position peaked at $1.77M in Q3 2013. 118 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2014.

Russell Frank Company reported no remaining Sanofi Contingent Value Rights position as of Q3 2014 after selling out during the quarter.
Russell Frank Company sold 200,000 Sanofi Contingent Value Rights shares in Q3 2014, an estimated $94K.
Russell Frank Company first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 5 quarters.
Russell Frank Company's Sanofi Contingent Value Rights position peaked at $1.77M in Q3 2013.
118 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2014.

Based on Russell Frank Company's 13F filing for Q3 2014, filed 12 Nov 2014.